Amgen Company Overview

What is the Stock Ticker for Amgen?

The stock ticker for Amgen is AMGN.

Where is the Amgen headquarters?

Thousand Oaks, California, United States

What Does Amgen Do?

Amgen is a biotechnology company that develops and manufactures innovative medicines for serious illnesses such as cancer, cardiovascular disease, and autoimmune disorders. They focus on discovering, developing, and delivering transformative medicines to improve the lives of patients worldwide.

How Does Amgen Make Money?

Amgen is a biotechnology company that makes money primarily through the sale of its products and services. The company's products include biologic therapies for the treatment of cancer, bone disease, and other serious illnesses. Amgen also provides research and development services to other companies in the biotechnology and pharmaceutical industries.

The company generates revenue from the sale of its products, which are marketed and sold through its own sales force and through partnerships with other companies. Amgen's products are sold in the United States and in international markets, with the majority of its revenue coming from the United States.

In addition to product sales, Amgen also generates revenue from research and development services. The company provides contract research services to other companies in the biotechnology and pharmaceutical industries, helping them to develop new drugs and therapies.

Amgen also generates revenue from licensing agreements and collaborations with other companies. The company has entered into partnerships with other biotechnology and pharmaceutical companies to develop and market new products, and it has licensed its technology and intellectual property to other companies for use in their own products.

Overall, Amgen's revenue is generated from a combination of product sales, research and development services, licensing agreements, and collaborations with other companies. The company's focus on biologic therapies for serious illnesses has allowed it to establish a strong presence in the biotechnology industry and generate significant revenue from its products and services.

Who Founded Amgen?

Amgen was founded by William K. Bowes Jr., George B. Rathmann, Joseph Rubinfeld, and Dennis Fenton in 1980.

What is the History of Amgen?

Amgen is a biotechnology company that was founded in 1980 by William K. Bowes Jr., a venture capitalist, and George B. Rathmann, a scientist and entrepreneur. The company's name is derived from the words "applied molecular genetics."

Amgen's first product was Epogen, a drug used to treat anemia in patients with chronic kidney disease. The drug was approved by the FDA in 1989 and quickly became a blockbuster, generating billions of dollars in revenue for the company.

In the years that followed, Amgen continued to develop and market innovative biologic drugs, including Neupogen, a drug used to boost white blood cell counts in cancer patients, and Enbrel, a drug used to treat autoimmune diseases such as rheumatoid arthritis.

Amgen has also been involved in several high-profile legal battles over the years, including a patent dispute with Roche over the drug Mircera and a lawsuit with the state of New York over allegations of illegal marketing practices.

Today, Amgen is one of the largest biotechnology companies in the world, with a market capitalization of over $130 billion. The company employs over 23,000 people and has operations in more than 100 countries.

What Industry is Amgen In?

Amgen is in the pharmaceutical/biotech industry.

What Are Amgen's Competitive Advantages?

1. Strong Research and Development Capabilities: Amgen invests heavily in research and development, which has enabled the company to develop a robust pipeline of innovative drugs. This has helped the company to stay ahead of its competitors in terms of product development.

2. Diversified Product Portfolio: Amgen has a diversified product portfolio that includes drugs for various therapeutic areas such as oncology, cardiovascular diseases, and bone health. This has helped the company to reduce its dependence on any single product and has provided a stable revenue stream.

3. Strong Brand Recognition: Amgen is a well-known brand in the pharmaceutical industry, which has helped the company to establish a strong reputation and gain the trust of healthcare professionals and patients.

4. Strong Distribution Network: Amgen has a strong distribution network that enables the company to reach a large number of customers across the globe. This has helped the company to expand its market share and increase its revenue.

5. Strong Financial Position: Amgen has a strong financial position, which has enabled the company to invest in research and development and expand its operations. This has helped the company to stay ahead of its competitors and maintain its competitive advantage.

What Are Amgen's Competitive Threats?

1. Competition from other biotech and pharmaceutical companies: Amgen faces competition from other companies that develop and market similar products, such as Roche, Novartis, and Pfizer.

2. Patent expirations: As patents for some of Amgen's key products expire, the company may face increased competition from generic drug manufacturers.

3. Regulatory challenges: Amgen operates in a highly regulated industry, and changes in regulations or delays in obtaining regulatory approvals could impact the company's ability to bring new products to market.

4. Pricing pressures: The healthcare industry is under increasing pressure to control costs, and payers may push back against high prices for Amgen's products.

5. Technological advancements: Advances in technology and new scientific discoveries could lead to the development of new treatments that compete with Amgen's products.

Who Are Some of the Competitors of Amgen?

Some of the competitors of Amgen include Roche, Novartis, Pfizer, Merck, and Johnson & Johnson.

What Are Some of Amgen's Products and Services?

Some notable products and services from Amgen include:

1. Enbrel - a medication used to treat autoimmune diseases such as rheumatoid arthritis and psoriasis.
2. Neulasta - a medication used to reduce the risk of infection in patients undergoing chemotherapy.
3. Prolia - a medication used to treat osteoporosis and bone loss.
4. Repatha - a medication used to lower cholesterol levels in patients with high cholesterol.
5. Kyprolis - a medication used to treat multiple myeloma.
6. Blincyto - a medication used to treat acute lymphoblastic leukemia.
7. AMGEVITA - a biosimilar medication used to treat autoimmune diseases such as rheumatoid arthritis and psoriasis.
8. Oncology Supportive Care - a range of services and products to support cancer patients and their caregivers.

Has Amgen Acquired any Companies?

Yes, Amgen has made several notable acquisitions, including the acquisition of Immunex Corporation in 2002 for $16 billion, the acquisition of Onyx Pharmaceuticals in 2013 for $10.4 billion, and the acquisition of deCODE Genetics in 2012 for $415 million.